Incyte Reports 2021 Second Quarter Financial Results and Provides Updates on Key Clinical Programs

August 3, 2021
11:05 am

Incyte Reports 2021 Second Quarter Financial Results and Provides Updates on Key Clinical Programs

WILMINGTON, Del.–(BUSINESS WIRE)–Incyte (Nasdaq:INCY) today reports 2021 second quarter financial results and provides a status update on the Companys development portfolio.
In the second quarter, we saw an acceleration of growth of Jakafi® (ruxolitinib)…

Click here to view the original article.

Business Wire, Global

Share this article

Netflix Cuts 1,000 Jobs as Stock Sinks 40%: Is a Bottom Near?

October 15, 2026

BlackRock Crypto ETF Assets Rise 63% in Q3, Still Below Last Year

October 15, 2026

Bitcoin slides towards US$81,000 as hot US inflation sparks fresh crypto sell-off

October 15, 2026

Analysts see 21% upside after Q3 earnings

October 15, 2026

Crypto scam crackdown shuts 241 websites as Brooklyn DA and FBI act

October 15, 2026

Japan, South Korea Stocks Slump in Early Trade; Kospi Drops Over 4%, SK Hynix Falls Over 6%, Kioxia Down Over 8%

October 15, 2026

Bitway Surges 5,000%. Will It Crash Next?

October 15, 2026

BaFin warns on 23 sites

October 15, 2026